Table 1.
Personal characteristics of participants who responded to Delphi surveys on multimorbidity measurement
| Characteristics | Professional panellists | Public panellists | ||||
| Round 1 (n=150) | Round 2 (n=112) | Round 3 (n=97) | Round 1 (n=25) | Round 2 (n=31) | Round 3 (n=25) | |
| Continent | ||||||
| Europe | 80 (53.3) | 59 (52.7) | 50 (51.5) | 21 (84.0) | 30 (96.8) | 24 (96.0) |
| North America | 31 (20.7) | 24 (21.4) | 22 (22.7) | 1 (4.0) | 0 | 0 |
| Australasia | 13 (8.7) | 12 (10.7) | 10 (10.3) | 0 | 0 | 0 |
| Asia | 20 (13.3) | 12 (10.7) | 11 (11.3) | 1 (4.0) | 0 | 0 |
| South America | 5 (3.3) | 4 (3.6) | 4 (4.1) | 1 (4.0) | 1 (3.2) | 1 (4.0) |
| Africa | 1 (0.6) | 1 (0.9) | 0 | 0 | 0 | 0 |
| Not stated | 0 | 0 | 0 | 1 (4.0) | 0 | 0 |
| Country income | ||||||
| High income | 139 (92.7) | 103 (92.0) | 89 (91.8) | 22 (88.0) | 30 (96.8) | 24 (96.0) |
| Low and middle income | 11 (7.3) | 9 (8.0) | 8 (8.2) | 2 (8.0) | 1 (3.2) | 1 (4.0) |
| Not stated | 0 | 0 | 0 | 1 (4.0) | 0 | 0 |
| Multimorbidity of participant | ||||||
| Yes | 17 (11.3) | 16 (14.3) | 13 (13.4) | 13 (52.0) | 19 (61.3) | 17 (68.0) |
| No | 133 (88.7) | 95 (84.8) | 83 (85.6) | 12 (48.0) | 12 (38.7) | 8 (32.0) |
| Not stated | 0 | 1 (0.9) | 1 (1.0) | 0 | 0 | 0 |
| Multimorbidity of participant's family or friends | ||||||
| Yes | 104 (69.3) | 76 (67.9) | 66 (68.0) | 17 (68.0) | 24 (77.4) | 20 (80.0) |
| No | 46 (30.7) | 35 (31.2) | 30 (30.9) | 8 (32.0) | 7 (22.6) | 5 (20.0) |
| Not stated | 0 | 1 (0.9) | 1 (1.0) | 0 | 0 | 0 |
| Area of work* | ||||||
| Research | 123 (82.0) | 94 (83.9) | 81 (83.5) | — | — | — |
| Public policy | 13 (8.7) | 9 (8.0) | 7 (7.2) | — | — | — |
| Clinical practice | 58 (38.7) | 43 (38.4) | 39 (40.2) | — | — | — |
| Teaching | 4 (2.7) | 3 (2.7) | 4 (4.1) | — | — | — |
| Main work setting | ||||||
| Government | 10 (6.7) | 6 (5.4) | 6 (6.2) | — | — | — |
| Academia | 95 (63.3) | 70 (65.5) | 57 (58.8) | — | — | — |
| Hospital | 18 (12.0) | 16 (14.3) | 16 (16.5) | — | — | — |
| Primary care | 25 (16.7) | 16 (14.3) | 14 (14.4) | — | — | — |
| Other | 2 (13.3) | 4 (3.6) | 4 (4.1) | — | — | — |
| Populations of interest* | ||||||
| General population | 100 (66.7) | 80 (71.4) | 69 (71.1) | — | — | — |
| Older people | 98 (65.3) | 67 (59.8) | 60 (61.9) | — | — | — |
| Middle aged and older | 89 (59.3) | 59 (52.7) | 53 (54.6) | — | — | — |
| Socially deprived | 85 (56.7) | 62 (55.4) | 56 (57.7) | — | — | — |
| Women† | 37 (24.7) | 33 (29.5) | 31 (32.0) | — | — | — |
| Men† | 33 (22.0) | 27 (24.1) | 26 (26.8) | — | — | — |
| Children | 19 (12.7) | 17 (15.2) | 16 (16.5) | — | — | — |
| Ethnic group/indigenous | — | 43 (38.4) | 40 (41.2) | — | — | — |
| People with disability | — | 46 (41.2) | 44 (45.4) | — | — | — |
| Age group (years) | ||||||
| 18-34 | — | — | — | 2 (8.0) | 1 (3.2) | 1 (4.0) |
| 35-54 | — | —– | — | 6 (24.0) | 7 (22.6) | 5 (20.0) |
| 55-64 | — | —– | — | 5 (20.0) | 7 (22.6) | 6 (24.0) |
| ≥65 | — | — | — | 12 (48.0) | 16 (51.6) | 13 (52.0) |
| Sex | ||||||
| Female† | — | — | — | 14 (56.0) | 19 (61.3) | 14 (56.0) |
| Male† | — | — | — | 11 (44.0) | 12 (38.7) | 11 (44.0) |
Data are number (%) of participants.
*Participants could choose more than one response so percentages can sum to >100%.
†Female and male refers to the sex of the public panellists; women and men refer to the populations that the professional panellists have research interests in.